Sequoia Financial Advisors »

Leap Therapeutics shares owned by Sequoia Financial Advisors

Quarter-by-quarter ownership of Leap Therapeutics (CYPH) shares owned by Sequoia Financial Advisors from 13F filings

Historical chart of Sequoia Financial Advisors investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Sequoia Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Sequoia Financial Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $56k 48k 1.16

More positions owned by Sequoia Financial Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Ea Series Trust Sequoia Global V (SFGV)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core Msci Total (IXUS)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Microsoft Corporation (MSFT)
Etf Ser Solutions Distillate Us (DSTL)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
J P Morgan Exchange Traded F Income Etf (JPIE)
Amazon (AMZN)
Pimco Etf Tr Multisector Bd (PYLD)
Blackrock Etf Trust Ii Ishares Flexible (BINC)
Vanguard Bd Index Fds Short Trm Bond (BSV)

View all positions for Sequoia Financial Advisors

Top funds holding Leap Therapeutics

BlackRock
Vanguard Group
Simplify Asset Management
Susquehanna International
Geode Capital Management
Group One Trading
State Street Corporation
Texas Capital Bank Wealth Management Services
Two Sigma Advisers
Northern Trust
Key Client Fiduciary Advisors
Citadel Advisors
Two Sigma Investments
Simplex Trading
Qube Research & Technologies

View all funds holding Leap Therapeutics